Exploring the oncogenic impact of heteroplasmic de novo MT-ND5 truncating mutations

Area of Science:

• Mitochondrial biology
• Cancer research
• Genetics

Background:

• Mitochondrial DNA (mtDNA) variants are linked to cancer, but causality is unclear.
• Understanding the role of specific mtDNA mutations in oncogenesis is crucial.

Purpose of the Study:

• To investigate the molecular mechanisms by which induced MT-ND5 mutations contribute to cancer.
• To establish and analyze heteroplasmic mtDNA mutations using base editing technology.

Main Methods:

• Induced de novo truncating mutations in MT-ND5 using DddA-derived cytosine base editors in HEK293 cells.
• Assessed mitochondrial function, cellular redox status, and oncogenic potential via in vitro and in vivo assays.
• Performed transcriptomic analysis to identify affected cellular pathways.

Main Results:

• Low to moderate heteroplasmy of MT-ND5 mutants impaired mitochondrial function and altered cellular redox status.
• Cells adapted to elevated reactive oxygen species (ROS) and energy crisis.
• Increased oncogenic potential, migration, invasion, and genome instability were observed.
• Downregulation of ROS scavenging pathways and alterations in epigenetic landscapes were noted.

Conclusions:

• MT-ND5 mutations drive cancer progression by increasing cellular ROS and genome instability.
• Altered redox balance and epigenetic landscapes are key consequences of these mutations.
• This study provides a mechanistic link between specific mtDNA mutations and cancer development.